WHO halts hydroxychloroquine, HIV drugs in Covid trials

The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with Covid-19 after they failed to reduce mortality. The setback came as the WHO also reported more than 200,000 new cases globally of the disease for the first time in a single